Filing Details
- Accession Number:
- 0001415889-24-001111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-16 16:59:34
- Reporting Period:
- 2024-01-12
- Accepted Time:
- 2024-01-16 16:59:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1192448 | Glaukos Corp | GKOS | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1705850 | E Joseph Gilliam | C/O Glaukos Corporation One Glaukos Way Aliso Viejo CA 92656 | President & Coo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-01-12 | 199 | $77.08 | 119,802 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2024-01-12 | 110 | $30.92 | 119,912 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-01-12 | 110 | $89.01 | 119,802 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-01-12 | 110 | $0.00 | 110 | $30.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,327 | 2028-03-14 | No | 4 | M | Direct |
Footnotes
- Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer.
- Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person.
- Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.
- The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.
- This option was granted on March 14, 2018 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and theremainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grantdate.
Billionaire Hedge Funds
